Area of research
Dermatology · Rheumatology
Research interest
Research interests include Dermatology and Skin Diseases, Urticaria and Related Conditions, Psoriasis: Treatment and Pathogenesis, and Medicine and Dermatology Studies History.
Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review.
Human dorsal root ganglion-based itch subcluster mapping and pathway analysis through single-nucleus RNA sequencing.
Nanostring Transcriptomic Analysis Highlights IL-6 Family and TGF-β Pathways in the Pathogenesis of Prurigo Nodularis
Identification of a Distinct Circulating CCL Chemokine Signature in Neuropathic Pruritus
Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation.
Prurigo nodularis: disease burden, clinical features and approach to management
Prevalence of prurigo nodularis in the United States.
Association of sleep disturbance and itch intensity with quality-of-life impairment and disease severity in prurigo nodularis.
Nemolizumab in prurigo nodularis up to 100 weeks: <scp>OLYMPIA LTE</scp> interim analysis
Prurigo nodularis: disease burden, clinical features and approach to management.
Association of human leukocyte antigen allelic variants with hidradenitis suppurativa across Fitzpatrick skin types: A cross-sectional analysis.
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies
Systemic immune profiling identifies elevated mas-related G-coupled receptor membrane X2 (MRGPRX2) with a distinct inflammatory signature in chronic pruritus of unknown origin.
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors.
Comprehensive plasma cytokine profiling reveals a distinct endotype of type 2 inflammation in chronic pruritus of unknown origin
Plasma cytokine profiling identifies early kidney injury and systemic inflammation in prurigo nodularis
Cigarette smoking, obesity and alcohol use among patients with prurigo nodularis.
Comorbidity burden and real-world treatment patterns of neuropathic pruritus: A retrospective cohort study.
Immunometabolic reprogramming in the management of prurigo nodularis with methotrexate.
Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis.
Patient perspectives on the lived experience of prurigo nodularis: A qualitative approach.
Epigenetic profiling reveals neuroimmune and fibrotic pathway dysregulation in prurigo nodularis.
Circulating IgE levels as a biomarker for treatment response to dupilumab among patients with prurigo nodularis.
Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Integrating skin color assessments into clinical practice and research: A review of current approaches
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis
Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation